ATG7 and cancer: Importantly, deletion of ATG7 in mice with pre-existing non-small cell lung cancer (NSCLC) stopped further tumor growth and promoted tumor cell death, before the destruction of normal tissues were detected [189], indicating that transient inhibition of autophagy may be therapeutically beneficial in cancer.